Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03321916 · ClinicalTrials.gov registry record · NA
MacTel Laser Study
A NA study, sponsored by The Lowy Medical Research Institute Limited.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03321916: Completed NA study, sponsored by The Lowy Medical Research Institute Limited.
NCT03321916 is a NA study that has completed, run by The Lowy Medical Research Institute Limited. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03321916, a NA study, has completed, sponsored by The Lowy Medical Research Institute Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a two armed Single Masked Pilot Study enrolling participants with Macular Telangiectasia Type 2 who will be randomized to undergo either a subthreshold photothermal treatment or a sham procedure to one eye. The participants will be followed for one year with visits at 1 month, 3 months, 6 months and 12 months post-treatment (laser or sham). Due to the small number of participants enrolled in this study the data will be analyzed by descriptive statistics and exploratory figures. Summary statistics will be produced for study and fellow eyes.
Primary Outcome
To evaluate the safety and tolerability of subthreshold photothermal therapy in patients with MacTel Type 2 as assessed by CTCAE v4.0
Interventions
- DEVICE 577-nm PASCAL laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT03321916 record still lists
NCT03321916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which 577-nm PASCAL laser is the first listed.
NCT03321916 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03321916 about?
NCT03321916 is a clinical study titled "MacTel Laser Study". This is a two armed Single Masked Pilot Study enrolling participants with Macular Telangiectasia Type 2 who will be randomized to undergo either a subthreshold photothermal treatment or a sham procedure to one eye. The participants will be followed for one year with visits at 1 month, 3 months, 6 mo...
What is the current status of trial NCT03321916?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-02-08. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03321916?
The interventions under investigation include: 577-nm PASCAL laser (DEVICE).
Who is sponsoring clinical trial NCT03321916?
This trial is sponsored by The Lowy Medical Research Institute Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03321916's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI